Anti-Human CD25 Therapeutic Antibody (Basiliximab)
Recombinant monoclonal antibody to Human CD25. Basiliximab (trade name Simulect) is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used to prevent rejection in organ transplantation, especially in kidney transplants. It is a chimeric CD25 monoclonal antibody of the IgG1 isotype. It acts as an antagonist at the interleukin-2(IL-2) binding site of the p55 subunit (Tac antigen) of the high affinity IL-2 receptor (CD25) on the surface of the activated T lymphocytes.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-004 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD25 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in FC, IP, ELISA, Neut, FuncS, IF, WB and most other immunological methods. |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |